Iowa Medicaid and semaglutide
Wegovy for weight loss: no. Prior authorization for heart risk in adults with established heart disease and BMI 27 or higher, or for the liver condition MASH. Ozempic for weight loss: no; for type 2 diabetes Iowa Medicaid must cover it. Read from Iowa Department of Health and Human Services, Iowa Medicaid documents Nov 6, 2026.
In 2025 Iowa Medicaid paid for 53,645 semaglutide prescriptions (Ozempic, Wegovy, Rybelsus), 61% of its GLP-1 prescriptions and 21st of the 50 states and DC. It reimbursed $52.3 million before rebates, $974 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Ozempic | 51,808 | $50.1 million | $968 |
| Wegovy | 971 | $1.3 million | $1,327 |
| Rybelsus | 866 | $850,730 | $982 |
Iowa plans and prescribing rules
State of Iowa employee PPO plan (Wellmark). The coverage manual for the State of Iowa's National Choice active employee PPO, effective January 1, 2026 and administered by Wellmark, lists weight reduction drugs among the drugs excluded from the pharmacy benefit.
Semaglutide in the states around Iowa
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| Iowa | 19 | $39/moWellmedr | 53,645 | Medicaid Wegovy: No |
| Illinois | 19 | $39/moWellmedr | 55,327 | Medicaid Wegovy: No |
| Minnesota | 19 | $39/moWellmedr | 165,896 | Medicaid Wegovy: Yes |
| Missouri | 18 | $39/moWellmedr | 75,811 | Medicaid Wegovy: No |
| Nebraska | 19 | $39/moWellmedr | 24,156 | Medicaid Wegovy: No |
| South Dakota | 19 | $39/moWellmedr | 7,210 | Medicaid Wegovy: No |
| Wisconsin | 19 | $39/moWellmedr | 87,468 | Medicaid Wegovy: No |



